摘要
联合腹腔动脉干切除可显著提高胰体尾癌的切除率,但是否可提高根治性及改善病人预后,特别是在该术式所导致的潜在缺血并发症等方面,仍存在较大争议。多数回顾性研究提示,对腹腔动脉干及其分支受累的胰体尾癌病人行联合腹腔动脉干切除的胰体尾癌根治术具有可行性并可使病人生存获益。该术式为非常规手术,开展时应严格掌握手术指征,在可获得R0切除的前提下,审慎评估其临床效果及潜在的缺血并发症。
Although lack of high quality evidences, most of retrospective research shows that distal pancreatectomy with celiac axis resection seems to be a safe and valuable option for selected patients of pancreatic body cancer involving celiac axis or/and its branches, and neoadjuvant therapy may bring additional survival benefits to these patients. Due to its relatively high perioperative risks, especially the ischemic morbidity, this procedure should only be performed after strict selection of cases aiming at R0 resection.
出处
《中国实用外科杂志》
CSCD
北大核心
2017年第3期262-265,共4页
Chinese Journal of Practical Surgery
基金
国家自然科学基金资助(No.81672353)
关键词
腹腔动脉干切除
胰体尾癌
新辅助治疗
celiac axis resection
pancreatic body cancer
neoadjuvant therapy
